Date: 2011-02-25
Type of information: Private placement
Company: Tigenix (Belgium)
Investors:
Amount: €15 million
Funding type: private placement
Planned used: Together withits combination with Celleric, the TiGenix also announces its intention to raise approximately €15 million through a public rights offering, of which €10 million has already been secured via precommitments from certain existing shareholders and new investors.
Others:
Therapeutic area: Autoimmune diseases – Inflammatory diseases - Rheumatic diseases
